BlackRock Institutional Trust Company, N.A. - RAPTOR PHARMACEUTICAL CORP ownership

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$20,496,000
+71.7%
2,284,943
+2.8%
0.00%
+50.0%
Q2 2016$11,940,000
+16.6%
2,223,444
-0.1%
0.00%0.0%
Q1 2016$10,236,000
-14.2%
2,225,194
-3.0%
0.00%0.0%
Q4 2015$11,924,000
-12.9%
2,293,056
+1.3%
0.00%0.0%
Q3 2015$13,697,000
-59.0%
2,263,949
+7.0%
0.00%
-60.0%
Q2 2015$33,405,000
+52.2%
2,115,561
+4.8%
0.01%
+66.7%
Q1 2015$21,946,000
+5.5%
2,018,913
+2.1%
0.00%0.0%
Q4 2014$20,807,000
+11.5%
1,977,841
+1.7%
0.00%0.0%
Q3 2014$18,657,000
-24.8%
1,945,487
-9.4%
0.00%
-25.0%
Q2 2014$24,813,000
+11.0%
2,148,346
-3.9%
0.00%0.0%
Q1 2014$22,355,000
-4.1%
2,235,481
+24.9%
0.00%0.0%
Q4 2013$23,301,000
+47.7%
1,789,603
+69.3%
0.00%
+33.3%
Q3 2013$15,773,000
+108.4%
1,057,146
+30.6%
0.00%
+50.0%
Q2 2013$7,569,000809,5660.00%
Other shareholders

There were no reported owners of RAPTOR PHARMACEUTICAL CORP in Q4 2016.

NameSharesValueWeighting ↓
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders